Patent applications and USPTO patent grants for Intercept Pharmaceuticals, Inc..The latest application filed is for "pharmaceutical compositions for combination therapy".
Patent | Date |
---|---|
Pharmaceutical Compositions For Combination Therapy App 20220280533 - PRUZANSKI; Mark ;   et al. | 2022-09-08 |
Pharmaceutical Compositions For Combination Therapy App 20220280534 - PRUZANSKI; Mark ;   et al. | 2022-09-08 |
Medicine obtained by combining FXR agonist and ARB Grant 11,419,878 - Namisaki , et al. August 23, 2 | 2022-08-23 |
Oral preparation of obeticholic acid Grant 11,413,295 - Matono , et al. August 16, 2 | 2022-08-16 |
Pharmaceutical Compositions Comprising A Fxr Agonist And A Fibrate For Use In The Treatment Of Cholestatic Liver Disease App 20220226350 - MACCONELL; Leigh A. ;   et al. | 2022-07-21 |
Methods Of Using Obeticholic Acid App 20220184099 - EDWARDS; Jeffrey ;   et al. | 2022-06-16 |
TGR5 modulators and methods of use thereof Grant 11,345,721 - Pellicciari , et al. May 31, 2 | 2022-05-31 |
Film-coated tablet having high chemical stability of active ingredient Grant 11,331,273 - Matono , et al. May 17, 2 | 2022-05-17 |
Compositions Of Obeticholic Acid And Methods Of Use App 20220133745 - LANCASTER; Richard Gail ;   et al. | 2022-05-05 |
3-desoxy derivative and pharmaceutical compositions thereof Grant 11,319,337 - Pellicciari , et al. May 3, 2 | 2022-05-03 |
Methods And Intermediates For The Preparation Of Bile Acid Derivatives App 20220127302 - PELLICCIARI; Roberto ;   et al. | 2022-04-28 |
Pharmaceutical compositions for combination therapy Grant 11,311,557 - Pruzanski , et al. April 26, 2 | 2022-04-26 |
Treatment And Prevention Of Intestinal Inflammatory Diseases With A Bile Acid Derivative App 20220096495 - CEULEMANS; Laurens ;   et al. | 2022-03-31 |
Preparation And Uses Of Obeticholic Acid App 20210395293 - STEINER; Andre ;   et al. | 2021-12-23 |
Treatment Of Fibrosis Using Fxr Ligands App 20210346400 - FIORUCCI; Stefano ;   et al. | 2021-11-11 |
Tgr5 Modulators And Methods Of Use Thereof App 20210269473 - PELLICCIARI; Roberto | 2021-09-02 |
Farnesoid X Receptor Modulators App 20210269475 - PELLICCIARI; Roberto ;   et al. | 2021-09-02 |
Farnesoid X Receptor Modulators App 20210228599 - PELLICCIARI; Roberto | 2021-07-29 |
Methods and intermediates for the preparation bile acid derivatives Grant 11,072,631 - Schaab , et al. July 27, 2 | 2021-07-27 |
Methods and intermediates for the preparation of bile acid derivatives Grant 11,066,437 - Pellicciari , et al. July 20, 2 | 2021-07-20 |
Farnesoid X receptor modulators Grant 11,034,717 - Pellicciari , et al. June 15, 2 | 2021-06-15 |
Crystalline Forms Of Obeticholic Acid App 20210139528 - GALVIN; Gabriel M. ;   et al. | 2021-05-13 |
Farnesoid x receptor modulators Grant 11,000,532 - Pellicciari May 11, 2 | 2021-05-11 |
Tgr5 Modulators And Methods Of Use Thereof App 20210122779 - PELLICCIARI; Roberto ;   et al. | 2021-04-29 |
Treatment of fibrosis using FXR ligands Grant 10,987,362 - Fiorucci , et al. April 27, 2 | 2021-04-27 |
3-desoxy Derivative And Pharmaceutical Compositions Thereof App 20210101927 - Pellicciari; Roberto ;   et al. | 2021-04-08 |
FXR agonist compositions for combination therapy Grant 10,894,054 - Pruzanski , et al. January 19, 2 | 2021-01-19 |
Treatment Of Fibrosis Using Fxr Ligands App 20200397803 - Fiorucci; Stefano ;   et al. | 2020-12-24 |
3-desoxy derivative and pharmaceutical compositions thereof Grant 10,815,267 - Pellicciari , et al. October 27, 2 | 2020-10-27 |
Steroids as agonists for FXR Grant RE48,286 - Pellicciari October 27, 2 | 2020-10-27 |
TGR5 modulators and methods of use thereof Grant 10,800,807 - Pellicciari , et al. October 13, 2 | 2020-10-13 |
Methods Of Diagnosis And Treatment Of Liver Diseases Using Obeticholic Acid App 20200316092 - EDWARDS; Jeffrey ;   et al. | 2020-10-08 |
Farnesoid X Receptor Modulators App 20200297739 - Pellicciari; Roberto | 2020-09-24 |
Compositions of obeticholic acid and methods of use Grant 10,758,549 - Lancaster , et al. Sep | 2020-09-01 |
Film-coated Tablet Having High Chemical Stability Of Active Ingredient App 20200268671 - MATONO; Mitsuhiro ;   et al. | 2020-08-27 |
Compositions of obeticholic acid and methods of use Grant 10,751,349 - Lancaster , et al. A | 2020-08-25 |
Methods And Intermediates For The Preparation Bile Acid Derivatives App 20200239515 - Schaab; Kevin ;   et al. | 2020-07-30 |
Compositions Of Obeticholic Acid And Methods Of Use App 20200171053A1 - | 2020-06-04 |
Pharmaceutical Compositions Of A Bile Acid Derivative And Microbiome And Uses Thereof App 20200164005 - Wu; Gary D ;   et al. | 2020-05-28 |
Isotopically Labeled Bile Acid Derivatives App 20200165290 - GALVIN; Gabriel ;   et al. | 2020-05-28 |
Methods Of Using Obeticholic Acid App 20200147108 - Edwards; Jeffrey ;   et al. | 2020-05-14 |
Compositions of obeticholic acid and methods of use Grant 10,646,499 - Lancaster , et al. | 2020-05-12 |
Methods for the preparation of obeticholic acid and derivatives thereof Grant 10,604,545 - Galvin | 2020-03-31 |
Methods for preparation of bile acids and derivatives thereof Grant 10,604,544 - Galvin | 2020-03-31 |
Compositions Of Obeticholic Acid And Methods Of Use App 20200054650 - Lancaster; Richard Gail ;   et al. | 2020-02-20 |
Compositions Of Obeticholic Acid And Methods Of Use App 20200046735 - Lancaster; Richard Gail ;   et al. | 2020-02-13 |
Compositions Of Obeticholic Acid And Methods Of Use App 20200046736 - Lancaster; Richard Gail ;   et al. | 2020-02-13 |
Methods of promoting hepatic regeneration Grant 10,548,906 - Jansen , et al. Fe | 2020-02-04 |
Methods for the preparation of obeticholic acid and derivatives thereof Grant 10,550,146 - List , et al. Fe | 2020-02-04 |
Crystalline Forms Of A Bile Acid Derivative App 20200024299 - Strazik; Rachel Pineda ;   et al. | 2020-01-23 |
Farnesoid X receptor modulators Grant 10,532,061 - Pellicciari Ja | 2020-01-14 |
Methods Of Treating Cancer App 20190298742 - Moschetta; Antonio ;   et al. | 2019-10-03 |
Steroids As Agonists For Fxr App 20190300564 - Pellicciari; Roberto | 2019-10-03 |
Steroids as agonists for FXR Grant 10,421,772 - Pellicciari Sept | 2019-09-24 |
Tgr5 Modulators And Methods Of Use Thereof App 20190284225 - PELLICCIARI; Roberto ;   et al. | 2019-09-19 |
Methods for preparation of bile acids and derivatives thereof Grant 10,414,791 - Pellicciari , et al. Sept | 2019-09-17 |
Compositions Of Obeticholic Acid And Methods Of Use App 20190255071 - Lancaster; Richard Gail ;   et al. | 2019-08-22 |
Methods of treating cancer Grant 10,369,160 - Moschetta , et al. | 2019-08-06 |
Methods For The Preparation Of Obeticholic Acid And Derivatives Thereof App 20190211052 - List; Benjamin ;   et al. | 2019-07-11 |
Farnesoid X Receptor Modulators App 20190209586 - Pellicciari; Roberto | 2019-07-11 |
Preparation and Uses of Obeticholic Acid App 20190153020 - Steiner; Andre ;   et al. | 2019-05-23 |
Treatment of fibrosis using FXR ligands Grant 10,258,633 - Fiorucci , et al. | 2019-04-16 |
Compositions Of Obeticholic Acid And Methods Of Use App 20190076446 - Lancaster; Richard Gail ;   et al. | 2019-03-14 |
Process for preparing bile acid derivatives Grant 10,202,414 - Pellicciari , et al. Feb | 2019-02-12 |
Methods For Preparation Of Bile Acids And Derivatives Thereof App 20190010184 - Pellicciari; Roberto ;   et al. | 2019-01-10 |
Preparation and uses of obeticholic acid Grant 10,174,073 - Steiner , et al. J | 2019-01-08 |
3-desoxy Derivative And Pharmaceutical Compositions Thereof App 20190002493 - Pellicciari; Roberto ;   et al. | 2019-01-03 |
Methods And Intermediates For The Preparation Of Bile Acid Derivatives App 20180371009 - Pellicciari; Roberto ;   et al. | 2018-12-27 |
Preparation and uses of obeticholic acid Grant 10,155,787 - Steiner , et al. Dec | 2018-12-18 |
Preparation and Uses of Obeticholic Acid App 20180305397 - Steiner; Andre ;   et al. | 2018-10-25 |
Methods Of Treating Cancer App 20180256600 - Moschetta; Antonio ;   et al. | 2018-09-13 |
Methods Of Promoting Hepatic Regeneration App 20180256602 - Jansen; Peter Leonardus Maria ;   et al. | 2018-09-13 |
Compositions of obeticholic acid and methods of use Grant 10,052,337 - Lancaster , et al. August 21, 2 | 2018-08-21 |
Preparation and uses of obeticholic acid Grant 10,047,117 - Steiner , et al. August 14, 2 | 2018-08-14 |
Methods For Preparation Of Bile Acids And Derivatives Thereof App 20180222937 - Galvin; Gabriel M | 2018-08-09 |
Preparation and uses of obeticholic acid Grant 9,982,008 - Steiner , et al. May 29, 2 | 2018-05-29 |
Pharmaceutical Compositions For Combination Therapy App 20180117065 - PRUZANSKI; Mark ;   et al. | 2018-05-03 |
Treatment of Pulmonary Disease App 20180064729 - Pruzanski; Mark ;   et al. | 2018-03-08 |
Methods For Modulating Bone Density App 20180042943 - Shapiro; David ;   et al. | 2018-02-15 |
TGR5 Modulators and Methods of Use Thereof App 20180016295 - Pellicciari; Roberto | 2018-01-18 |
Pharmaceutical Compositions For Combination Therapy App 20180008616 - Pruzanski; Mark ;   et al. | 2018-01-11 |
Steroids as Agonists for FXR App 20170305961 - Pellicciari; Roberto | 2017-10-26 |
Methods Of Treating Cancer App 20170296556 - Moschetta; Antonio ;   et al. | 2017-10-19 |
Process for preparing bile acid derivatives Grant 9,777,038 - Pellicciari , et al. October 3, 2 | 2017-10-03 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions Grant 9,763,964 - Pellicciari , et al. September 19, 2 | 2017-09-19 |
3-desoxy Derivative And Pharmaceutical Compositions Thereof App 20170260225 - Pellicciari; Roberto ;   et al. | 2017-09-14 |
Preparation and uses of obeticholic acid Grant 9,732,116 - Steiner , et al. August 15, 2 | 2017-08-15 |
Steroids as agonists for FXR Grant 9,732,117 - Pellicciari August 15, 2 | 2017-08-15 |
Preparation and Uses of Obeticholic Acid App 20170226149 - Steiner; Andre ;   et al. | 2017-08-10 |
Farnesoid X Receptor Modulators App 20170216316 - Pellicciari; Roberto | 2017-08-03 |
Treatment Of Fibrosis Using Fxr Ligands App 20170165277 - Fiorucci; Stefano ;   et al. | 2017-06-15 |
TGR5 modulators and methods of use thereof Grant 9,650,409 - Pellicciari May 16, 2 | 2017-05-16 |
Farnesoid X Receptor Modulators App 20170101434 - Pellicciari; Roberto ;   et al. | 2017-04-13 |
Farnesoid X receptor modulators Grant 9,611,289 - Pellicciari April 4, 2 | 2017-04-04 |
Compositions Of Obeticholic Acid And Methods Of Use App 20170035784 - Lancaster; Richard Gail ;   et al. | 2017-02-09 |
TGR5 modulators and methods of use thereof Grant 9,540,414 - Pellicciari January 10, 2 | 2017-01-10 |
Treatment of fibrosis using FXR ligands Grant 9,498,484 - Fiorucci , et al. November 22, 2 | 2016-11-22 |
Treatment of Pulmonary Disease App 20160213689 - Pruzanski; Mark ;   et al. | 2016-07-28 |
Preparation and Uses of Obeticholic Acid App 20160215014 - Steiner; Andre ;   et al. | 2016-07-28 |
Preparation and Uses of Obeticholic Acid App 20160176913 - Steiner; Andre ;   et al. | 2016-06-23 |
Steroids as Agonists for FXR App 20160152657 - Pellicciari; Roberto | 2016-06-02 |
Preparation and Uses of Obeticholic Acid App 20160108082 - Steiner; Andre ;   et al. | 2016-04-21 |
TGR5 Modulators and Methods of Use Thereof App 20160096862 - Pellicciari; Roberto | 2016-04-07 |
Preparation and Uses of Obeticholic Acid App 20160074419 - Steiner; Andre ;   et al. | 2016-03-17 |
Tgr5 Modulators And Methods Of Use Thereof App 20160052956 - Pellicciari; Roberto | 2016-02-25 |
TGR5 modulators and methods of use thereof Grant 9,243,027 - Pellicciari January 26, 2 | 2016-01-26 |
Preparation and uses of obeticholic acid Grant 9,238,673 - Steiner , et al. January 19, 2 | 2016-01-19 |
Bile Acid Derivatives as FXR Ligands for the Prevention or Treatment of FXR-Mediated Diseases or Conditions App 20150359805 - Pellicciari; Roberto ;   et al. | 2015-12-17 |
Process For Preparing Bile Acid Derivatives App 20150291653 - Pellicciari; Roberto ;   et al. | 2015-10-15 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions Grant 9,090,652 - Pellicciari , et al. July 28, 2 | 2015-07-28 |
Steroids as Agonists for FXR App 20150166598 - Pellicciari; Roberto | 2015-06-18 |
TGR5 modulators and methods of use thereof Grant 8,999,964 - Pellicciari April 7, 2 | 2015-04-07 |
Steroids as agonists for FXR Grant 8,969,330 - Pellicciari March 3, 2 | 2015-03-03 |
TGR5 modulators and methods of use thereof Grant 8,796,249 - Pellicciari August 5, 2 | 2014-08-05 |
Treatment of Pulmonary Disease App 20140148428 - Pruzanski; Mark ;   et al. | 2014-05-29 |
TGR5 Modulators and Methods of Use Thereof App 20140100209 - Pellicciari; Roberto | 2014-04-10 |
TGR5 Modulators and Methods of Use Thereof App 20140094443 - Pellicciari; Roberto | 2014-04-03 |
Bile Acid Derivatives as FXR Ligands for the Prevention or Treatment of FXR-Mediated Diseases or Conditions App 20140057886 - Pellicciari; Roberto ;   et al. | 2014-02-27 |
Steroids as Agonists for FXR App 20140024631 - Pellicciari; Roberto | 2014-01-23 |
Preparation and Uses of Obeticholic Acid App 20130345188 - Steiner; Andre ;   et al. | 2013-12-26 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions Grant 8,546,365 - Pellicciari , et al. October 1, 2 | 2013-10-01 |
TGR5 modulators and methods of use thereof Grant 8,445,472 - Pellicciari May 21, 2 | 2013-05-21 |
23-substituted bile acids as TGR5 modulators and methods of use thereof Grant 8,410,083 - Pellicciari April 2, 2 | 2013-04-02 |
Steroids as agonists for FXR Grant 8,377,916 - Pellicciari February 19, 2 | 2013-02-19 |
Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatment Of FXR-Mediated Diseases Or Conditions App 20120283234 - Pellicciari; Roberto ;   et al. | 2012-11-08 |
TGR5 Modulators and Methods of Use Thereof App 20120115832 - Pellicciari; Roberto | 2012-05-10 |
Steroids as Agonists for FXR App 20120053163 - Pellicciari; Roberto | 2012-03-01 |
TGR5 modulators and methods of use thereof Grant 8,114,862 - Pellicciari February 14, 2 | 2012-02-14 |
Steroids as agonists for FXR Grant 8,058,267 - Pellicciari November 15, 2 | 2011-11-15 |
Process for preparing 3a(.beta.)-7a(.beta.)-dihydroxy-6a(.beta.)-alkyl-5.beta.-cholanic acid Grant 7,994,352 - Ferrari , et al. August 9, 2 | 2011-08-09 |
TGR5 Modulators And Methods Of Use Thereof App 20110172198 - Pellicciari; Roberto | 2011-07-14 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions Grant 7,932,244 - Pellicciari , et al. April 26, 2 | 2011-04-26 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions Grant 7,858,608 - Pellicciari , et al. December 28, 2 | 2010-12-28 |
Steroid agonist for FXR Grant 7,812,011 - Pellicciari October 12, 2 | 2010-10-12 |
Steroids as agonists for FXR Grant 7,786,102 - Pellicciari August 31, 2 | 2010-08-31 |
Tgr5 Modulators And Methods Of Use Therof App 20100152151 - Pellicciari; Roberto | 2010-06-17 |
Bile Acid Derivatives As Fxr Ligands For The Prevention Or Treatment Of Fxr-mediated Diseases Or Conditions App 20100063018 - Pellicciari; Roberto ;   et al. | 2010-03-11 |
Steroids As Agonists For Fxr App 20100022498 - Pellicciari; Roberto | 2010-01-28 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions App 20080182832 - Pellicciari; Roberto ;   et al. | 2008-07-31 |
Novel Steroid Agonist For Fxr App 20080039435 - Pellicciari; Roberto | 2008-02-14 |
Steroids as agonists for FXR App 20070142340 - Pellicciari; Roberto | 2007-06-21 |
Method of reducing drug-induced adverse side effects in a patient App 20060252670 - Fiorucci; Stefano ;   et al. | 2006-11-09 |
Treatment of fibrosis using FXR ligands App 20060069070 - Fiorucci; Stefano ;   et al. | 2006-03-30 |
NCAGE Code | 7MWA6 | INTERCEPT PHARMACEUTICALS, INC.!DBA INTERCEPT |
CAGE Code | 7MWA6 | INTERCEPT PHARMACEUTICALS, INC. INTERCEPT |
S.A.M. Registration | 7MWA6 [966658416] | INTERCEPT PHARMACEUTICALS, INC. INTERCEPT |
SEC | 0001270073 | INTERCEPT PHARMACEUTICALS, INC. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.